Stratis can officially announce their partnership with MediConnect, the company behind blockchain solutions aimed at the pharmaceutical industry. MediConnect will prevent the prescribing of drugs to patients of medication from multiple pharmacies, reduce addiction, provide traceability of drugs from manufacturers, wholesalers, prescribers and pharmacies all the way through to patients, enabling the removal of false medicines and the easy recall of drugs within pharmaceutical systems.
MediConnect will utilize the Stratis Technology Stack to build a suite of offerings set to meet the needs of pharmacies, resolving issues such as prescription drug abuse, drug provenance, payment loyalty schemes and gateway solutions.
Chris Trew, CEO and Founder of Stratis Group Ltd stated;
This is an exciting time for Stratis. MediConnect will become another customer of Stratis, utilizing our consultancy services to build and deliver a bespoke blockchain solution set to revolutionise the medical industry.
A number of Stratis’s technologies will be utilized by the MediConnect Blockchain solution, they will leverage the production ready Full Node in C#, Smart Contracts in C# and the recently released Stratis DLT offering.
Dexter Blackstock, Director of MediConnect stated:
Stratis was a natural selection for us. We have already established relationships within the medical industry and government to understand the real problems within the space. This has enabled us to design such a solution, leveraging Stratis’ solutions in a familiar programming language.
MediConnect will begin laying the foundations from Q2 2019 with a pilot, comprising of 8-10 pharmacies. Their ICO will launch early 2019, utilizing the Stratis ICO Platform.
You can find out more about MediConnect at their newly announced website.